We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.6B
AUM Growth
+$879M
(+4.7%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-6.05%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
589
New
74
Increased
137
Reduced
233
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$96.2M |
| 2 |
DraftKings
DKNG
|
+$81.7M |
| 3 |
GE HealthCare
GEHC
|
+$81.1M |
| 4 |
GFL Environmental
GFL
|
+$77M |
| 5 |
Vaxcyte
PCVX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$187M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$143M |
| 3 |
AbbVie
ABBV
|
+$112M |
| 4 |
Walt Disney
DIS
|
+$99.6M |
| 5 |
HSKA
Heska Corp
HSKA
|
+$80.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 10.17% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Descartes Systems
DSGX
$6.48B
| $68.9K | ﹤0.01% |
860
+92
| +12% | +$7.17K |
|
452
Gartner
IT
$10.4B
| $68K | ﹤0.01% |
194
-63
| -25% | -$20.5K |
|
453
Ameriprise Financial
AMP
$48.3B
| $64.4K | ﹤0.01% |
194
| – | – |
|
454
Aecom
ACM
$9.57B
| $63.9K | ﹤0.01% |
755
-972
| -56% | -$79.7K |
|
455
Kenvue
KVUE
$37.9B
| $61.3K | ﹤0.01% |
+2,321
| New | +$60.5K |
|
456
Regeneron Pharmaceuticals
REGN
$72.9B
| $60.4K | ﹤0.01% |
84
-62,665
| -100% | -$48.3M |
|
457
Tradeweb Markets
TW
$22.2B
| $59.4K | ﹤0.01% |
867
-23,415
| -96% | -$1.66M |
|
458
MarketAxess Holdings
MKTX
$4.34B
| $54.4K | ﹤0.01% |
208
+36
| +21% | +$10.7K |
|
459
Arrow Electronics
ARW
$10.8B
| $53.6K | ﹤0.01% |
+374
| New | +$46.6K |
|
460
Cencora
COR
$62.2B
| $53.5K | ﹤0.01% |
278
-425
| -60% | -$73.5K |
|
461
PTC
PTC
$14.7B
| $51.5K | ﹤0.01% |
362
-220
| -38% | -$29.1K |
|
462
Toll Brothers
TOL
$14.5B
| $51.1K | ﹤0.01% |
+646
| New | +$43.3K |
|
463
Axalta
AXTA
$7.58B
| $49.2K | ﹤0.01% |
+1,499
| New | +$46.5K |
|
464
Pinterest
PINS
$13.6B
| $45.7K | ﹤0.01% |
1,671
-81,682
| -98% | -$2.04M |
|
465
Darden Restaurants
DRI
$23.7B
| $45.6K | ﹤0.01% |
+273
| New | +$42.9K |
|
466
Linde
LIN
$236B
| $44.6K | ﹤0.01% |
+117
| New | +$42.7K |
|
467
Keysight
KEYS
$52.2B
| $44.2K | ﹤0.01% |
264
-240
| -48% | -$37.2K |
|
|
MASI
468
DELISTED
Masimo
MASI
| $43.8K | ﹤0.01% |
266
-8,210
| -97% | -$1.43M |
|
469
Landstar System
LSTR
$6.29B
| $43.5K | ﹤0.01% |
226
+124
| +122% | +$22.4K |
|
470
Everest Group
EG
$15.8B
| $42.4K | ﹤0.01% |
124
| – | – |
|
471
National Vision
EYE
$1.75B
| $41.6K | ﹤0.01% |
1,712
-81,365
| -98% | -$1.89M |
|
472
RenaissanceRe
RNR
$13.9B
| $41.4K | ﹤0.01% |
222
| – | – |
|
473
Align Technology
ALGN
$12.6B
| $38.2K | ﹤0.01% |
108
-12,765
| -99% | -$4.06M |
|
474
Royal Gold
RGLD
$16.6B
| $38.1K | ﹤0.01% |
+332
| New | +$42.7K |
|
|
NATI
475
DELISTED
National Instruments Corp
NATI
| $31.1K | ﹤0.01% |
542
-1,674
| -76% | -$95.9K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2023 Portfolio in Review
As of Q2 2023, Fred Alger Management held 589 positions worth $19.6B, up 4.7% from $18.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fred Alger Management withdrew a net $1.18B in Q2 2023, closing 78 positions and reducing 233 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in DraftKings worth $94.2M.
- Fred Alger Management's largest Q2 2023 buy was DraftKings: 3,544,411 shares worth $94.2M.
- Fred Alger Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $96.2M increase.
- Fred Alger Management's biggest Q2 2023 reduction was Intuit, cutting an estimated $187M.
- Fred Alger Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $143M.
- Fred Alger Management's ten largest holdings make up 34% of its $19.6B portfolio in Q2 2023.
- Fred Alger Management opened 74 new positions and closed 78 in Q2 2023.
- Fred Alger Management's portfolio value rose 4.7% quarter-over-quarter to $19.6B.
Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.